Bukwang Pharmaceutical Co., Ltd. (KRX:003000)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,400.00
+60.00 (1.80%)
At close: Aug 13, 2025, 3:30 PM KST
1.80%
Market Cap342.86B
Revenue (ttm)173.50B
Net Income (ttm)-798.97M
Shares Out98.66M
EPS (ttm)-12.08
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume377,786
Average Volume758,875
Open3,340.00
Previous Close3,340.00
Day's Range3,310.00 - 3,415.00
52-Week Range3,200.00 - 6,090.00
Beta0.75
RSI52.00
Earnings DateAug 7, 2025

About Bukwang Pharmaceutical

Bukwang Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products in South Korea and internationally. It offers its products in oral solid dosage forms, injections, oral solutions, external solutions, and ointments. The company also provides ethical drugs, including drugs for treating diabetic peripheral neuropathy, hypothyroidism, toxic liver disease, chronic hepatitis, liver cirrhosis, and iron-deficiency anemia; over-the-counter drugs, such as fever and pain relief medication, gastrointestinal medication, cold medication... [Read more]

Sector Healthcare
Founded 1960
Employees 606
Stock Exchange Korea Stock Exchange
Ticker Symbol 003000
Full Company Profile

Financial Performance

In 2024, Bukwang Pharmaceutical's revenue was 160.09 billion, an increase of 27.13% compared to the previous year's 125.93 billion. Losses were -2.64 billion, -91.57% less than in 2023.

Financial Statements

News

There is no news available yet.